Expanding Innovations’ X-PAC LLIF Earns FDA OK

Expanding Innovations, a spinal implant company that designs non-screw based expandable cage tech, has achieved U.S. Food and Drug Administration (FDA) 510(k) clearance for its X-PAC expandable lateral cage system (X-PAC LLIF).

According to the company, the approval is a significant addition to its expandable product portfolio, which also features its flagship X-PAC expandable posterior cage system (X-PAC TLIF).

Dr. K. Brandon Strenge, Orthopaedic Institute of Western Kentucky, told the press, "The X-PAC Expandable Lateral Cage System is the first implant I have seen that addresses the core principals of lateral lumbar interbody fusion. The maximized posterior expansion facilitates indirect decompression, the open architecture ensures a bridging bone fusion, and the multiple lordotic options allow proper implant selection for restoration of sagittal balance. These benefits, coupled with the ability to insert the cage at a nominal height, then dial it up via controlled expansion, make X-PAC Lateral an exciting and beneficial technology to offer my patients moving forward."

Expanding Innovations will feature the new X-PAC LLIF and X-PAC TLIF at this year’s AAOS annual meeting and Spine Summit annual meeting.